Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
ULIFETEC SAS is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is being processed by 1 distinct examiner in 1 distinct art unit, suggesting a focused approach to its current patent filings. The concentration in a single art unit indicates that the company's current legal focus is on a specific biological or pharmaceutical innovation.
The 1 distinct examiner assigned to the 1 pending office action represents the only point of contact for the company's current prosecution matters. This avoids the administrative burden of managing multiple examiner relationships or differing art unit procedures. Practitioners can focus their strategy on the specific feedback and historical patterns of this single examiner.
KIM, YOUNG J is the busiest examiner for the portfolio, with 1 pending office action. As there is only 1 busiest examiner pending, the company's immediate patent goals are entirely dependent on the progress of this single action. The 1 pending office action constitutes the full extent of the company's current pending workload in this technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, YOUNG J | 1 | 64.8% | +18.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18036439 | METHOD | KIM, YOUNG J | 155d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18036439 | METHOD | KIM, YOUNG J | 155d overdue |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18036439 | METHOD | KIM, YOUNG J | 1681 | §101§103§112 | Non-Final OA | 155d overdue | Pending | May 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial